0001209191-17-030214.txt : 20170505
0001209191-17-030214.hdr.sgml : 20170505
20170505122657
ACCESSION NUMBER: 0001209191-17-030214
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170503
FILED AS OF DATE: 20170505
DATE AS OF CHANGE: 20170505
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CymaBay Therapeutics, Inc.
CENTRAL INDEX KEY: 0001042074
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943103561
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7999 GATEWAY BLVD
STREET 2: SUITE 130
CITY: NEWARK
STATE: CA
ZIP: 94560
BUSINESS PHONE: 510-293-8800
MAIL ADDRESS:
STREET 1: 7999 GATEWAY BLVD
STREET 2: SUITE 130
CITY: NEWARK
STATE: CA
ZIP: 94560
FORMER COMPANY:
FORMER CONFORMED NAME: METABOLEX, INC.
DATE OF NAME CHANGE: 20090721
FORMER COMPANY:
FORMER CONFORMED NAME: METABOLEX INC
DATE OF NAME CHANGE: 19970710
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Menold Daniel
CENTRAL INDEX KEY: 0001705745
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36500
FILM NUMBER: 17817169
MAIL ADDRESS:
STREET 1: C/O CYMABAY THERAPEUTICS, INC.
STREET 2: 7999 GATEWAY BLVD., SUITE 130
CITY: NEWARK
STATE: CA
ZIP: 94560
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-05-03
0
0001042074
CymaBay Therapeutics, Inc.
CBAY
0001705745
Menold Daniel
C/O CYMABAY THERAPEUTICS, INC.
7999 GATEWAY BLVD., SUITE 130
NEWARK
CA
94560
0
1
0
0
Vice President, Finance
Stock Option (right to buy)
3.45
2017-05-03
4
A
0
35000
0.00
A
2027-05-02
Common Stock
35000
35000
D
The shares subject to the option shall become vested and exercisable according to the following schedule: 25% of the shares subject to the option shall vest on April 27, 2018, and the remaining shares shall vest in equal monthly installments over the next 36 months.
/s/ Daniel Menold
2017-05-05